Harbour Investments Inc. grew its stake in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 12,103.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 14,766 shares of the medical equipment provider’s stock after buying an additional 14,645 shares during the period. Harbour Investments Inc.’s holdings in Align Technology were worth $1,955,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Align Technology during the 2nd quarter worth about $745,370,000. Assenagon Asset Management S.A. raised its stake in Align Technology by 638.7% during the third quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock worth $629,469,000 after acquiring an additional 4,031,284 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its holdings in Align Technology by 3,162.7% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock valued at $278,342,000 after purchasing an additional 2,033,451 shares during the last quarter. Vontobel Holding Ltd. grew its stake in shares of Align Technology by 69,628.9% during the third quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock valued at $183,335,000 after purchasing an additional 1,383,526 shares during the last quarter. Finally, Danske Bank A S raised its holdings in Align Technology by 1,366,764.0% during the 3rd quarter. Danske Bank A S now owns 683,432 shares of the medical equipment provider’s stock worth $90,426,000 after purchasing an additional 683,382 shares during the last quarter. 88.43% of the stock is owned by institutional investors and hedge funds.
Align Technology Price Performance
ALGN stock opened at $163.96 on Thursday. The company has a market cap of $11.56 billion, a P/E ratio of 23.87, a PEG ratio of 2.12 and a beta of 1.74. The firm has a 50-day moving average of $152.24 and a 200 day moving average of $168.57. Align Technology, Inc. has a 1 year low of $131.95 and a 1 year high of $200.43.
Align Technology (NASDAQ:ALGN – Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.77 by $0.03. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same period last year, the firm earned $2.61 earnings per share. The business’s quarterly revenue was up 1.9% on a year-over-year basis. On average, equities research analysts expect that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on ALGN. Needham & Company LLC reiterated a “hold” rating on shares of Align Technology in a report on Thursday, October 29th. Robert W. Baird lowered shares of Align Technology from an “outperform” rating to a “neutral” rating and decreased their target price for the company from $218.00 to $162.00 in a report on Thursday, October 15th. Raymond James Financial reiterated a “buy” rating on shares of Align Technology in a report on Monday, October 5th. Stifel Nicolaus reduced their price objective on shares of Align Technology from $210.00 to $175.00 and set a “buy” rating on the stock in a research note on Friday, October 9th. Finally, Evercore cut shares of Align Technology from an “outperform” rating to an “in-line” rating and set a $155.00 price target on the stock. in a research report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $193.08.
Check Out Our Latest Stock Report on Align Technology
About Align Technology
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Read More
- Five stocks we like better than Align Technology
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
